Skip to main content
Clinical Trials/ISRCTN65588717
ISRCTN65588717
Completed
未知

Implantation Of Biofreedom® drug-coated stents with very short dual antiplatelet therapy In patients at high bleeding risk: real-world data

niversity Hospital of Muenster0 sites89 target enrollmentDecember 18, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Patients with coronary artery disease and indication for PCI
Sponsor
niversity Hospital of Muenster
Enrollment
89
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/31965195/ (added 27/09/2021)

Registry
who.int
Start Date
December 18, 2018
End Date
February 1, 2019
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity Hospital of Muenster

Eligibility Criteria

Inclusion Criteria

  • 1\. Implantation of at least one Biofreedom® stent for the treatment of significant CAD during the study period
  • 2\. At least one criterion for high risk bleeding

Exclusion Criteria

  • 1\. Aged \<18 years
  • 2\. Current pregnancy
  • 3\. Underlying malignant disease
  • 4\. Active bleeding
  • 5\. Unable to give informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials